BRIACELL THERAPEUTICS CORP. Equity And Liabilities
BRIACELL THERAPEUTICS CORP. (BCTX) had Equity And Liabilities of $46.46 million as of 2022-04-30, per its 6-K filed 2022-06-13.
Discontinued › Notes
ifrs-full:EquityAndLiabilities · last filed 2022-06-13
- 2020-07-31: Equity And Liabilities 641.68K CAD.
- 2019-08-01: Equity And Liabilities 546.26K CAD.
CAD
| Period end | Equity And Liabilities |
|---|---|
| 2020-07-31 | 641.68K CAD 40-F/A · filed 2021-11-16 |
| 2019-08-01 | 546.26K CAD 40-F/A · filed 2021-11-16 |
USD
| Period end | Equity And Liabilities |
|---|---|
| 2022-04-30 | $46.46M 6-K · filed 2022-06-13 |
| 2022-01-31 | $48.55M 6-K · filed 2022-03-15 |
| 2021-07-31 | $58.04M 6-K · filed 2022-06-13 |
| 2020-07-31 | $522.33K 40-F/A · filed 2021-11-16 |
| 2019-08-01 | $444.66K 40-F/A · filed 2021-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |